Detrol La is a prescription medication used to treat the symptoms of overactive bladder. It belongs to a class of drugs known as antimuscarinics that work by blocking certain nerve signals. The active ingredient, tolterodine tartrate, inhibits muscarinic receptors in the bladder detrusor muscle. This inhibition reduces involuntary contractions that cause urgency, frequency, and leakage. By decreasing these muscle spasms the drug helps patients gain better bladder control. The overall effect is a reduction in the need for frequent trips to the bathroom and a decrease in urgency sensations.

Detrol La is a prescription medication classified as an antimuscarinic agent used primarily for the treatment of overactive bladder. It is formulated as an extended-release capsule that delivers the active ingredient over a 24-hour period. The drug works by blocking acetylcholine receptors in the bladder detrusor muscle, thereby reducing involuntary contractions. This blockade helps to increase bladder capacity and decrease the frequency of urgent urination and leakage episodes. By selectively targeting muscarinic receptors, Detrol La minimizes systemic effects on other tissues that rely on cholinergic signaling. The extended-release mechanism ensures a steady plasma concentration, maintaining therapeutic efficacy throughout the day and night. The primary pharmacological activity of the medication is the reduction of detrusor overactivity, which translates into improved symptom control for patients with bladder urgency. Overall, Detrol La functions as a targeted antimuscarinic that modulates bladder smooth muscle activity to alleviate the manifestations of overactive bladder.

Dry mouth may occur as the medication reduces fluid secretion in the oral cavity. Constipation is a common gastrointestinal effect reported by some users. Dizziness can affect balance and should be monitored especially when standing up quickly. Blurred vision may happen due to changes in eye muscle control. Some individuals experience urinary retention making it harder to empty the bladder completely. Headaches are frequently listed among the reported adverse reactions. Nausea sometimes accompanies the use of this medication. Fatigue or a general feeling of low energy may be observed in certain patients.

Detrol La is an extended-release formulation of oxybutynin used for overactive bladder. It works by relaxing the bladder muscles to reduce urgency and frequency. Common side effects include dry mouth, constipation, and mild stomach discomfort. Some users experience dizziness, drowsiness, or blurred vision, especially when standing up quickly. Less frequent effects may involve urinary retention, reduced sweating, or skin rash. Because the drug is absorbed slowly, side effects often develop gradually over several days. These observations are part of the known profile of the medication.